RSS   Newsletter   Contact   Advertise with us

Shire appoints Thomas Dittrich as CFO

Staff Writer | Dublin, Ireland | November 21, 2017
Thomas DittrichNovember 21, 2017, Dublin, Ireland - Shire, a biopharmaceutical company, announced that Thomas Dittrich will join the company as chief financial officer, and become an executive member of the board of directors and a member of the executive committee.
Mr. Dittrich will assume his roles at Shire in early 2018 following a transition period from his current employer.

Mr. Dittrich is currently Chief Financial Officer and a member of the Executive Committee at Sulzer Ltd, a publicly-listed, global industrial engineering and manufacturing company.

Mr. Dittrich joined Sulzer in August 2014, serving as Chief Executive Officer ad interim between August 2015 and December 2015.

At Sulzer, he was instrumental in designing the company’s transformation program and drove key upgrades to finance and IT functions, as well as to capital structure and resource allocation initiatives.

Prior to joining Sulzer, Mr. Dittrich served as Vice President, Finance Corporate Planning and Chief Accounting Officer of Amgen Inc. between 2010 and 2014.

Between 2006 and 2010, he was Vice President, Finance and Chief Financial Officer of Amgen International.

Mr. Dittrich also spent eight years with Dell where he held various finance and general manager roles.

Earlier in his career, Mr. Dittrich worked at Booz & Co and Helbing Management Consulting AG in operational and merger and acquisition roles, respectively.